Background illustration for clinical trials search

Paid Clinical Trials Seattle

Discover 1,443 paid clinical trials in Seattle, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

for
Metastatic Castration-Resistant Prostate Carcinoma,
Location: Seattle WA, Edmonds WA, Portland OR, Post Falls ID,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: Male

Age: 18+

Code: NCT07200830

Phase3, Recruiting

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

for
Anaplastic Large Cell Lymphoma, ALK-Negative,
Location: Seattle WA, Edmonds WA, Issaquah WA, Everett WA,
Sponsor: Eastern Cooperative Oncology Group

Sex: All

Age: 18 - 70+

Code: NCT06724237

Phase3, Recruiting

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

for
B Acute Lymphoblastic Leukemia
Location: Seattle WA, Edmonds WA, Portland OR, Newberg OR,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18 - 39

Code: NCT03150693

Phase3, Recruiting

Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma

for
Lymphoplasmacytic Lymphoma, Waldenstrom Macroglobulinemia
Location: Seattle WA, Edmonds WA, Issaquah WA, Portland OR,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT04840602

Phase2, Recruiting

Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations

for
Locally Advanced Pancreatic Adenocarcinoma,
Location: Seattle WA, Edmonds WA, Silverdale WA, Issaquah WA,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT06998940

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

for
Acute Myeloid Leukemia
Location: Seattle WA, Edmonds WA, Issaquah WA, Post Falls ID,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06672146

Phase2, Recruiting

FORWARD CAD IDE Study

for
Coronary Arterial Disease (CAD)
Location: Seattle WA, Bellevue WA, Portland OR, San Francisco CA,
Sponsor: Shockwave Medical, Inc.

Sex: All

Age: 18+

Code: NCT06662500

Recruiting

ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Seattle WA, Edmonds WA, Issaquah WA, Vancouver WA,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT06876714

Phase3, Recruiting

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

for
Prostate Cancer
Location: Seattle WA, Tacoma WA, Palo Alto CA, Santa Barbara CA,
Sponsor: Novartis Pharmaceuticals

Sex: Male

Age: 18 - 70+

Code: NCT06855277

Phase3, Recruiting

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia
Location: Seattle WA, Edmonds WA, Portland OR, Oregon City OR,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 65+

Code: NCT07321652

Phase3, Recruiting

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Seattle WA, Great Falls MT, Sacramento CA, Billings MT,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07061964

Phase2, Recruiting

Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)

for
Core Binding Factor Acute Myeloid Leukemia
Location: Seattle WA, Edmonds WA, Issaquah WA, Post Falls ID,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 59

Code: NCT06917911

Phase2, Recruiting

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

for
Endometrial Adenocarcinoma,
Location: Seattle WA, Edmonds WA, Issaquah WA, Portland OR,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT05112601

Phase2, Recruiting

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

for
Pancreatic Neoplasm
Location: Seattle WA, Edmonds WA, Issaquah WA, Everett WA,
Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 50 - 70+

Code: NCT04239573

Recruiting

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

for
Prostate Cancer (Adenocarcinoma)
Location: Seattle WA, Bellevue WA, Kirkland WA, Edmonds WA,
Sponsor: Canadian Cancer Trials Group

Sex: Male

Age: 18+

Code: NCT06592924

Phase3, Recruiting

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

for
High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements,
Location: Seattle WA, Portland OR, Post Falls ID,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06649812

Phase2, Recruiting

Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of Reduction

for
Central Line Associated Blood Stream Infections (CLABSI)
Location: Seattle WA, Edmonds WA, Everett WA, Olympia WA,
Sponsor: Swedish Medical Center

Sex: All

Age: 18+

Code: NCT07108660

Recruiting

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

for
Castration-Resistant Prostate Carcinoma,
Location: Seattle WA, Edmonds WA, Portland OR, Chico CA,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT06632977

Phase2, Recruiting

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

for
Advanced Malignant Solid Neoplasm,
Location: Seattle WA, Renton WA, Edmonds WA, Issaquah WA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0+

Code: NCT05564377

Phase2, Recruiting

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

for
Acute Myeloid Leukemia,
Location: Seattle WA, Edmonds WA, Issaquah WA, Portland OR,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 59

Code: NCT05554406

Phase2, Recruiting

As one of the fastest growing cities in America, Seattle stands out as a pivotal location for clinical research. Home to an extensive healthcare network and prominent research institutions, Seattle offers innovative approaches to clinical research and a significant contribution to medical science.

Leading centers such as the Fred Hutchinson Cancer Research Center, the University of Washington Medical Center, and the Seattle Children's Research Institute are at the forefront of groundbreaking studies.

Why choose Seattle for clinical trials?

For those considering participating in a clinical trial, there are several reasons why Seattle is a prime choice. The city is home to a robust network of leading research institutions, which are known for their pioneering work and advanced medical research. Seattle’s collaborative environment and emphasis on innovation enhance the quality and impact of clinical studies.

By participating in a clinical trial in Seattle, you gain access to some of the most advanced research and treatments available, while also contributing to significant medical discoveries. The city's commitment to cutting-edge science and a supportive research infrastructure make it an ideal location for advancing medical knowledge and improving future healthcare outcomes.

Common conditions studied in Seattle

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Seattle